with your knowledge as a pathologist, would you agree that the success of this approach depends on the quality of the biopsy (i.e. obtaining a sample that faithfully represents the entire volume of tissue being investigated)? From my experience with prostate cancer screening research I know that biopsy scoring of prostate tumors can be very inaccurate compared to pathology scoring after a prostatectomy.